Anand Shewale

Anand Shewale

AbbVie Inc - Chicago / United States
Economics & Econometrics / Economics
AD Scientific Index ID: 4457690
-
person_outline Anand Shewale's MOST POPULAR ARTICLES
1-) Adherence to rivaroxaban, dabigatran, and apixaban for stroke prevention in incident, treatment-naive nonvalvular atrial fibrillationJD Brown, AR Shewale, JC TalbertJournal of managed care & specialty pharmacy 22 (11), 1319-1329, 2016832016
2-) Cost-effectiveness of oral anticoagulants for ischemic stroke prophylaxis among nonvalvular atrial fibrillation patientsA Shah, A Shewale, CJ Hayes, BC MartinStroke 47 (6), 1555-1561, 2016682016
3-) Ubrogepant, an acute treatment for migraine, improved patient‐reported functional disability and satisfaction in 2 single‐attack phase 3 randomized trials, ACHIEVE I and IIDW Dodick, RB Lipton, J Ailani, RB Halker Singh, AR Shewale, S Zhao, ...Headache: The Journal of Head and Face Pain 60 (4), 686-700, 2020612020
4-) Adherence to rivaroxaban, dabigatran, and apixaban for stroke prevention for newly diagnosed and treatment-naive atrial fibrillation patients: an update using 2013-2014 dataJD Brown, AR Shewale, JC TalbertJournal of managed care & specialty pharmacy 23 (9), 958-967, 2017582017
5-) Comparison of low-, moderate-, and high-molecular-weight hyaluronic acid injections in delaying time to knee surgeryAR Shewale, CL Barnes, LA Fischbach, ST Ounpraseuth, JT Painter, ...The Journal of arthroplasty 32 (10), 2952-2957. e21, 2017392017